# FDA Inspection 1274217 - Tissue Regenix, Inc. - June 24, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/tissue-regenix-inc/de367324-d1c7-452c-87ed-b3d92b0238a3
Source feed: FDA_Inspections

> FDA Inspection 1274217 for Tissue Regenix, Inc. on June 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274217
- Company Name: Tissue Regenix, Inc.
- Inspection Date: 2025-06-24
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274217 - 2025-06-24](https://www.globalkeysolutions.net/records/fda_inspections/tissue-regenix-inc/b88f5120-ea7d-49b4-bc36-0a5d70651bc3)

Company: https://www.globalkeysolutions.net/companies/tissue-regenix-inc/f8ff802f-2aca-48e2-8819-6d16231fe8d2

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d